<DOC>
	<DOCNO>NCT00561327</DOCNO>
	<brief_summary>The purpose study determine whether losartan metabolite effective induce PPARγ target gene monocytes losartan-treated patient .</brief_summary>
	<brief_title>PPARgamma Activation Losartan Hypertensive Patients : The Importance Losartan-Metabolites</brief_title>
	<detailed_description>The losartan metabolite EXP3179 potently induce activity peroxisome proliferator-activated receptor γ ( PPAR-γ ) partial agonist vitro . PPAR-γ nuclear hormone receptor function regulator lipid- glucose metabolism . PPAR-γ ligand improve insulin sensitivity glucose tolerance , reduce cardiovascular morbidity mortality diabetic patient . Angiotensin II receptor 1-blocking PPAR-γ-activating property losartan metabolite patient would markedly improve pharmacological profile losartan combine anti-hypertensive highly beneficial metabolic action . We develop follow hypothesis : 1 . Hypertensive patient chronically treat losartan exhibit sufficient plasma level EXP3179 activate PPARγ . 2 . PPARγ target gene induce monocyte losartan-treated patient .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Age : 1980 Sex : male female Prior diagnosis treat hypertension Treatment losartan 100mg/daily least past 2 month ( n=20/ case ) ; : prior angiotensin receptor 1blocker treatment last 2 month ( n=10/ control ) . Nonsteroidal antiinflammatory drug ( exception : Acetyl salicylic acid ) past 21 day ( due structural homology glitazones , activate effect PPARγ ) Therapy glitazones past 21 day .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>hypertension</keyword>
	<keyword>angiotensin receptor blocker</keyword>
	<keyword>peroxisome proliferator activate receptor gamma</keyword>
</DOC>